Lupin Limited has informed the Exchange regarding a press release dated Jun 21, 2023, titled "Lupin Receives Approval from U.S. FDA for Tiotropium Dry Powder Inhaler.".
Lupin Limited has informed the Exchange regarding a press release dated Jun 21, 2023, titled "Lupin Receives Approval from U.S. FDA for Tiotropium Dry Powder Inhaler.".